Paxchem Revenue and Competitors

Claim your profile

Mumbai, India

Location

N/A

Total Funding

Chemicals

Industry

Employee Data

  • Paxchem has 103 Employees.(i)
  • Paxchem grew their employee count by 2% last year.
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
N/A19279%N/AN/A
#2
N/A81-16%N/AN/A
#3
N/A14-22%N/AN/A
#4
N/A19138%N/AN/A
#5
N/A20-13%N/AN/A
#6
N/A39-11%N/AN/A
#7
N/A236127%N/AN/A
#8
N/A431127%N/AN/A
#9
N/A17859%N/AN/A
#10
N/A12940%N/AN/A

Paxchem Ltd. (part of Pax Group of Companies), with ISO 9000 & 14000, OHSAS 18000, cGMP (ICH Q7a & FDA), GLP, and prestigious D&B Supplier Sustainability, EcoVadis Silver - Certifications has been manufacturing & marketing Speciality Chemicals such as Industrial Biocides, Preservatives, Anti-microbials, and Disinfectant Actives for almost 40 years. With more than 1,200 Customers in 18 Countries located in South East Asia (SEA), Gulf Cooperation Council (GCC), North Africa & Middle East (NAMET) region in over 25 different Applications Areas, Paxchem is presently one of the largest and most competent Regional Companies in its area of operation. Paxchem offers more than 150 specialized Cost-Effective and Bio-Effective Solutions to its Customer's problems. Paxchem specializes in assisting its Customers and Business Partners in managing the Bio-deterioration or Microbial Contamination vide Intelligent Solutions so that Customer's Product Quality or Reputation does not suffer. Paxchem Product Performance Assurances are backed by comprehensive Technical Evaluations and Third Party Certifications.

keywords:N/A

N/A

Total Funding

103

Number of Employees

N/A

Revenue (est)

2%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Paxchem News

12/07/2017 - India's new biocides rules expected within months

But strong disagreements between industry players have hindered progress, Ashok Pathare from chemical manufacturer Paxchem said at the ...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$7.5M1031%N/A
#2
$11.3M10317%N/A
#3
N/A10330%N/A
#4
N/A1031%N/A
#5
$6.2M104-3%N/A